Innovation Medical Management Co., Ltd.

Symbol: 002173.SZ

SHZ

8.86

CNY

Market price today

  • -107.2347

    P/E Ratio

  • 0.1986

    PEG Ratio

  • 3.91B

    MRK Cap

  • 0.00%

    DIV Yield

Innovation Medical Management Co., Ltd. (002173-SZ) Financial Statements

On the chart you can see the default numbers in dynamics for Innovation Medical Management Co., Ltd. (002173.SZ). Companys revenue shows the average of 483.51 M which is 0.134 % gowth. The average gross profit for the whole period is 115.05 M which is 0.199 %. The average gross profit ratio is 0.262 %. The net income growth for the company last year performance is -0.536 % which equals -2.722 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Innovation Medical Management Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.025. In the realm of current assets, 002173.SZ clocks in at 733.059 in the reporting currency. A significant portion of these assets, precisely 583.16, is held in cash and short-term investments. This segment shows a change of -0.114% when juxtaposed with last year's data. The debt profile of the company shows a total long-term debt of 20.327 in the reporting currency. This figure signifies a year_over_year change of 0.173%. Shareholder value, as depicted by the total shareholder equity, is valued at 1870.152 in the reporting currency. The year over year change in this aspect is -0.018%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 106.972, with an inventory valuation of 41.81, and goodwill valued at 0.99, if any. The total intangible assets, if present, are valued at 129.56.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004

balance-sheet.row.cash-and-short-term-investments

2371.68583.2658.5799.8
939.8
940.7
618.3
560.8
1334.3
98.6
23.6
41.3
64.2
32.7
35.5
63.8
39.4
101.8
55.1
15
13.2

balance-sheet.row.short-term-investments

-32.0220.10574
593.5
61.4
45.5
0
-18.6
-14.7
0
0
-5.8
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

410.4510760.994.3
135.1
225.1
423.5
293
215.5
91
139.4
167.3
153.4
163
149.3
154.2
153.1
113.2
103.8
69.1
29.4

balance-sheet.row.inventory

157.5941.849.343
34.5
53.5
48.8
729.1
757.5
729.9
715.3
667.3
616.1
568.3
530.1
470.2
385.6
323.3
170.4
134.8
78.6

balance-sheet.row.other-current-assets

8.091.132.9
10.6
8.3
638.5
786.9
1
1
1.1
-2.3
1.3
-5
-7
-4.4
-3.1
-2.8
-12.6
-6.6
-4.1

balance-sheet.row.total-current-assets

2947.81733.1771.6940
1120
1227.7
1728.9
2369.8
2308.2
920.5
879.4
873.6
835
759
708
683.8
575.1
535.6
316.6
212.3
117.1

balance-sheet.row.property-plant-equipment-net

5372.281349.81375.51397
1390.3
1392.4
1274
1035.6
982.4
86.6
97.7
103.9
81.3
52.3
52
51.8
53.1
39
32.6
29
20

balance-sheet.row.goodwill

3.95111
0
127
1018
1016.3
1016.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

502.52129.6121.8125.2
128.7
132
123.1
131.2
134.4
34.1
41.4
50.2
74.4
76.1
53.7
26.1
18.7
19.8
21.2
9.4
6.8

balance-sheet.row.goodwill-and-intangible-assets

506.47130.5122.8126.2
128.7
259
1141.1
1147.5
1150.7
34.1
41.4
50.2
74.4
76.1
53.7
26.1
18.7
19.8
21.2
9.4
6.8

balance-sheet.row.long-term-investments

94.5-4.917.9-554.3
22.6
28.9
0
0
41
18.2
0
0
9.3
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

59.971714.413.8
8.4
30.5
13.5
20.8
21.1
13.5
13.9
13.6
12.4
8.7
5.9
2.4
1.5
1.4
2.8
1
0.3

balance-sheet.row.other-non-current-assets

117.4355.937.4633.5
7.5
29.6
107.7
76.4
63.6
0.2
8.5
10
0.5
9.5
8.8
9.4
8.7
5.4
2.3
1.5
0

balance-sheet.row.total-non-current-assets

6150.641548.415681616.2
1557.6
1740.4
2536.3
2280.3
2258.8
152.6
161.4
177.6
177.9
146.6
120.3
89.6
82
65.5
58.9
40.8
27.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

9098.452281.52339.72556.2
2677.5
2968
4265.3
4650.2
4567
1073.1
1040.8
1051.2
1012.9
905.6
828.3
773.5
657.1
601.1
375.6
253.1
144.3

balance-sheet.row.account-payables

766.16208.1210.1183.4
180.5
166.6
99.6
87.1
90.2
13.9
27.8
28.8
11.3
19.4
21.4
44.3
25.4
34.6
42.6
5.2
8

balance-sheet.row.short-term-debt

157.1348.236.929.9
52.5
56.6
294
266
263.2
445.8
464.6
352
324.1
375.2
335
306.6
214.9
186.9
156.6
136.8
43

balance-sheet.row.tax-payables

18.086.65.85.9
7.5
8.9
20.8
67
57.8
32.7
33.1
30
27.5
26.9
19.9
5.3
1.7
-11.6
-3.6
-7.9
-2.7

balance-sheet.row.long-term-debt-total

80.7820.321.633.9
9
39
66.5
42.4
84.9
4.8
4.8
100
100
0
0
0
0
0
10
0
0

Deferred Revenue Non Current

16.994.24.85.2
5.8
3.6
4.4
5.2
6
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

177.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

58.66070.146
29.7
6.1
84.6
532.7
9.6
4
16.5
9.7
1.7
1.9
2.5
2.8
14.3
33.9
31
13.8
10.6

balance-sheet.row.total-non-current-liabilities

338.585112219.3
174.7
182.3
170.5
108.3
240.3
4.9
4.8
109.4
109.4
0.1
0.1
0.1
0.1
0
10
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

80.7820.321.633.9
44.6
22.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1566.11410.4434.4565.3
533.1
498.1
648.7
994.2
1035
659.7
562.2
549.7
492.7
439.6
393.9
369.6
265.5
251.2
241.4
150.8
62.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

1800.21449453.1453.6
454.9
454.9
454.9
456
456.9
202.2
205
205
205.5
201
100.5
100.5
67
67
50
50
50

balance-sheet.row.retained-earnings

-5168.47-1304.2-1269.7-1184.2
-1079
-764.4
382.4
398.3
257.6
142.8
208.2
219
205
181.1
153.3
127.6
117.5
83
45.8
24.3
12.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

286143.843.440.1
32.3
43.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

8035.942681.52677.52680.3
2735.2
2735.2
2778.6
2801.2
2817.1
68.3
65.4
77.5
67.7
42.4
141.1
138.7
170.8
169.2
14.7
10.9
7.7

balance-sheet.row.total-stockholders-equity

7528.691870.21904.31989.8
2143.4
2469
3615.9
3655.5
3531.6
413.4
478.6
501.5
478.2
424.5
394.9
366.7
355.3
319.2
110.5
85.2
70.4

balance-sheet.row.total-liabilities-and-stockholders-equity

9098.452281.52339.72556.2
2677.5
2968
4265.3
4650.2
4567
1073.1
1040.8
1051.2
1012.9
905.6
828.3
773.5
657.1
601.1
375.6
253.1
144.3

balance-sheet.row.minority-interest

3.650.90.91.1
1
0.9
0.7
0.4
0.4
0
0
0
42
41.5
39.4
37.1
36.3
30.7
23.7
17.1
11.7

balance-sheet.row.total-equity

7532.331871.11905.21990.9
2144.4
2469.9
3616.5
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

9098.45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

62.4815.217.919.8
593.5
61.4
45.5
18.7
22.4
3.5
3.5
3.5
3.5
3.5
3.5
3.5
3.5
0
0
0
0

balance-sheet.row.total-debt

237.9168.558.463.8
61.5
95.6
360.5
308.4
348.1
450.7
469.4
452
424.1
375.2
335
306.6
214.9
186.9
166.6
136.8
43

balance-sheet.row.net-debt

-2093.02-494.5-600.1-161.9
-284.7
-783.6
-212.3
-252.4
-986.2
352.1
445.7
410.7
359.9
342.5
299.5
242.8
175.5
85.1
111.5
121.8
29.8

Cash Flow Statement

The financial landscape of Innovation Medical Management Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.423. The company recently extended its share capital by issuing 0, marking a difference of -0.891 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 2.39 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -415340829.270 in the reporting currency. This is a shift of -1.903 from the previous year. In the same period, the company recorded 106.66, 0.9, and -23, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -1.46 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -10.51, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004

cash-flows.row.net-income

-35.11-34.3-73.9-105.1
-314.4
-1149.8
29.9
140.8
114.8
-65.3
-10.8
24.7
38.6
32.1
31.1
12.7
42.9
40
30.3
18.4
20.8

cash-flows.row.depreciation-and-amortization

6.63106.7110.3117.5
111.8
104.4
94.7
92.5
83.3
9
8.2
7.8
7.4
6.2
5.9
5.6
5.2
4.3
3.7
1.4
0.7

cash-flows.row.deferred-income-tax

0-3.2-1.4-3.9
21.4
-18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

03.21.43.9
-21.4
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-79.95-439.818.9
138
76.2
-140.5
-38.4
7.3
57.5
-12.7
-63.6
-57.6
-74.2
-45
-74.6
-129.3
-154
-46.9
-102.4
-29

cash-flows.row.account-receivables

-49.07-49.13611.7
60
61.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

6.826.8-6.7-8
17.2
-4.8
0.4
10.8
-15
-14.6
-48
-51.2
-47.8
-38.2
-59.9
-84.6
-62.3
-152.9
-35.6
-56.2
-21.5

cash-flows.row.account-payables

02.4-18.119.1
39.4
37.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-37.7-3.2-1.4-3.9
21.4
-18
-140.9
-49.1
22.3
72.1
35.3
-12.4
-9.8
-36.1
15
10
-67
-1.1
-11.3
-46.2
-7.6

cash-flows.row.other-non-cash-items

89.42-18.3-70.712
196.3
1065.5
145.3
11.2
44.8
32.3
25.9
35.4
40.8
26.4
17.5
17.2
21.5
11.9
16.4
9.1
2.4

cash-flows.row.net-cash-provided-by-operating-activities

-19.01000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-90.18-96.2-123.2-110.7
-108.4
-160.5
-399.9
-164.6
-181
-3.8
-16.7
-28.2
-28.1
-9.8
-49.7
-13
-9.3
-13.8
-9.1
-14.4
-6.8

cash-flows.row.acquisitions-net

0.130.30.235.6
34.3
80
120.6
0.4
0
0
8
7
0
0
0
13
0
0
0
0
0

cash-flows.row.purchases-of-investments

-320.4-320-30-695
-1271
-510
-1712.2
-2750
-6.7
0
-2.6
-8.8
0
0
0
-0.6
-3.5
0
0
0
0

cash-flows.row.sales-maturities-of-investments

625.03-0.3612.7710.5
742.7
1116.7
1887.2
1992.8
40.3
0.7
0.9
0.9
0.6
0.6
0.6
1.2
0
0
0
0
0

cash-flows.row.other-investing-activites

-14.960.90.37.2
1
-1.6
-16.2
8.2
44.7
0
0
28
0
0.5
0
-13
0.1
5
5
-10
0

cash-flows.row.net-cash-used-for-investing-activites

-104.93-415.3460-52.4
-601.3
524.6
-120.5
-913.2
-102.7
-3.1
-10.4
-1
-27.5
-8.7
-49
-12.4
-12.7
-8.8
-4.1
-24.3
-6.8

cash-flows.row.debt-repayment

-63-23-12-33
-29.2
-366.7
-325.7
-295.3
-607.6
-507.2
-589.6
-434.5
-598.2
-496.5
-485.5
-444
-465.6
-382.4
-309.4
-132
-24.9

cash-flows.row.common-stock-issued

00048.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

000-48.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-1.66-1.5-0.8-2.4
-3.7
-11.9
-64.5
-14.7
-22.6
-27
-32.2
-28.4
-37.5
-24.7
-18.1
-15.8
-18
-13.8
-11.1
-6.5
-2.1

cash-flows.row.other-financing-activites

50.2-10.59.8-76.1
-30.5
64.1
393.3
243.7
1732.5
579
604.8
431.5
655.6
536.8
514.8
535.8
493.5
554.4
366.3
228.1
50.8

cash-flows.row.net-cash-used-provided-by-financing-activities

11.54-5-3-111.4
-63.5
-314.5
3
-66.3
1102.3
44.8
-17
-31.4
19.8
15.5
11.3
75.9
9.9
158.2
45.7
89.6
23.8

cash-flows.row.effect-of-forex-changes-on-cash

-0.03000
0
0
0
0
0
0
0
-0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-112.43-409.3432.6-120.4
-533.1
306.5
12
-773.5
1249.8
75.3
-16.7
-28.3
21.5
-2.7
-28.3
24.4
-62.4
51.7
45.1
-8.2
11.8

cash-flows.row.cash-at-end-of-period

2002.99249658.3225.7
346.1
879.3
572.8
560.8
1334.3
84.5
9.2
25.9
54.2
32.7
35.5
63.8
39.4
101.8
50.1
5
13.2

cash-flows.row.cash-at-beginning-of-period

2115.42658.3225.7346.1
879.3
572.8
560.8
1334.3
84.5
9.2
25.9
54.2
32.7
35.5
63.8
39.4
101.8
50.1
5
13.2
1.4

cash-flows.row.operating-cash-flow

-19.0111-24.443.4
131.7
96.4
129.4
206.1
250.2
33.5
10.6
4.3
29.2
-9.5
9.5
-39.2
-59.7
-97.7
3.5
-73.5
-5.2

cash-flows.row.capital-expenditure

-90.18-96.2-123.2-110.7
-108.4
-160.5
-399.9
-164.6
-181
-3.8
-16.7
-28.2
-28.1
-9.8
-49.7
-13
-9.3
-13.8
-9.1
-14.4
-6.8

cash-flows.row.free-cash-flow

-109.18-85.2-147.6-67.4
23.3
-64.1
-270.4
41.5
69.2
29.7
-6
-24
1.1
-19.4
-40.2
-52.1
-69
-111.5
-5.6
-87.9
-12

Income Statement Row

Innovation Medical Management Co., Ltd.'s revenue saw a change of 0.135% compared with the previous period. The gross profit of 002173.SZ is reported to be 92.21. The company's operating expenses are 126.43, showing a change of 3.193% from the last year. The expenses for depreciation and amortization are 106.66, which is a -0.033% change from the last accounting period. Operating expenses are reported to be 126.43, which shows a 3.193% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.642% year-over-year growth. The operating income is -25.64, which shows a -0.642% change when compared to the previous year. The change in the net income is -0.536%. The net income for the last year was -34.29.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004

income-statement-row.row.total-revenue

802.72805.6709.7711.5
724.2
872.2
1058.9
905.1
762.8
137
183.3
299.2
369
336.9
292.3
284.2
344.1
292
238.6
192.2
151.4

income-statement-row.row.cost-of-revenue

714.85713.4679.1665.4
696.4
803.1
667.4
544.8
467.6
91
112.3
178.5
235.4
224.3
201.1
216.1
240.7
203
164
149.5
116.4

income-statement-row.row.gross-profit

87.8792.230.646.2
27.8
69.1
391.5
360.3
295.2
46
71
120.7
133.6
112.6
91.2
68.1
103.4
89
74.7
42.7
35.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

25.73---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

9.18---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-8.35-9.383.783
85.6
94
-25.5
-26.4
-6
0
2.2
5.3
-1.3
1.5
1
1.1
-0.8
2.1
1.5
0.6
0.8

income-statement-row.row.operating-expenses

122.74126.4122.5125.5
129.4
150.6
142.7
118.9
105.4
85.7
59.8
56.6
54.3
44.7
32.8
34.6
26.9
23.9
17.3
9.5
6.5

income-statement-row.row.cost-and-expenses

837.59839.8801.6790.9
825.8
953.7
810.1
663.7
573
176.7
172.1
235.1
289.6
268.9
233.9
250.7
267.6
226.9
181.2
159
122.9

income-statement-row.row.interest-income

18.5717.414.613.1
7.2
6.2
4.7
9
10.6
0.4
1
0.9
0.6
0.6
0.3
0.6
0.4
0.6
0.5
0.2
0.2

income-statement-row.row.interest-expense

3.493.63.46.1
7.6
20.1
35.7
25
44.5
26.6
31.6
28.4
28.1
25
18.3
15.8
18.2
13.9
11.2
6.7
2.3

income-statement-row.row.selling-and-marketing-expenses

9.18---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-8.35-9.3-3.72.3
-183.4
-1068.9
-151.4
-31.5
-29.9
-24.5
-20.5
-33.1
-36
-29.3
-20.4
-15.9
-22
-12
-16.5
-9.1
-1.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-8.35-9.383.783
85.6
94
-25.5
-26.4
-6
0
2.2
5.3
-1.3
1.5
1
1.1
-0.8
2.1
1.5
0.6
0.8

income-statement-row.row.total-operating-expenses

-8.35-9.3-3.72.3
-183.4
-1068.9
-151.4
-31.5
-29.9
-24.5
-20.5
-33.1
-36
-29.3
-20.4
-15.9
-22
-12
-16.5
-9.1
-1.6

income-statement-row.row.interest-expense

3.493.63.46.1
7.6
20.1
35.7
25
44.5
26.6
31.6
28.4
28.1
25
18.3
15.8
18.2
13.9
11.2
6.7
2.3

income-statement-row.row.depreciation-and-amortization

-2.41106.7110.3117.5
62.8
43.8
94.7
92.5
83.3
9
8.2
7.8
7.4
6.2
5.9
5.6
5.2
4.3
3.7
1.4
0.7

income-statement-row.row.ebitda-caps

-29.94---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-27.53-25.6-71.6-107.2
-101.5
-81.5
122.9
236.3
166
-63.9
-11.5
25.8
44.7
37.2
36.9
16.4
55.3
50.9
39.3
23.6
26.1

income-statement-row.row.income-before-tax

-35.87-35-75.3-104.8
-285
-1150.4
97.4
210
159.9
-64.2
-9.3
31
43.3
38.7
37.9
17.6
54.5
53
40.9
24.1
27

income-statement-row.row.income-tax-expense

-0.7-0.7-1.40.3
29.5
-0.6
67.4
69.2
45.1
1.1
1.6
6.3
4.7
6.5
6.9
4.9
11.6
13.1
10.6
5.7
6.2

income-statement-row.row.net-income

-35.11-34.3-73.9-105.1
-314.4
-1149.8
29.7
140.7
114.7
-65.3
-10.8
23.7
38.2
30
28.8
11.8
37.4
35.4
26.2
15.4
17.2

Frequently Asked Question

What is Innovation Medical Management Co., Ltd. (002173.SZ) total assets?

Innovation Medical Management Co., Ltd. (002173.SZ) total assets is 2281472772.000.

What is enterprise annual revenue?

The annual revenue is 399763679.000.

What is firm profit margin?

Firm profit margin is 0.109.

What is company free cash flow?

The free cash flow is -0.246.

What is enterprise net profit margin?

The net profit margin is -0.044.

What is firm total revenue?

The total revenue is -0.034.

What is Innovation Medical Management Co., Ltd. (002173.SZ) net profit (net income)?

The net profit (net income) is -34287743.350.

What is firm total debt?

The total debt is 68543479.000.

What is operating expences number?

The operating expences are 126432642.000.

What is company cash figure?

Enretprise cash is 543823060.000.